Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter

The comprehensive molecular characterization of gastric and gastroesophageal junction adenocarcinomas has led to the improvement of targeted and more effective treatments. As a result, several biomarkers have been introduced into clinical practice and the implementation of innovative diagnostic tool...

Descripción completa

Detalles Bibliográficos
Autores principales: Businello, Gianluca, Angerilli, Valentina, Lonardi, Sara, Bergamo, Francesca, Valmasoni, Michele, Farinati, Fabio, Savarino, Edoardo, Spolverato, Gaya, Fassan, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Consensus Conference
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852175/
https://www.ncbi.nlm.nih.gov/pubmed/35834132
http://dx.doi.org/10.1007/s13304-022-01330-5
_version_ 1784872555470913536
author Businello, Gianluca
Angerilli, Valentina
Lonardi, Sara
Bergamo, Francesca
Valmasoni, Michele
Farinati, Fabio
Savarino, Edoardo
Spolverato, Gaya
Fassan, Matteo
author_facet Businello, Gianluca
Angerilli, Valentina
Lonardi, Sara
Bergamo, Francesca
Valmasoni, Michele
Farinati, Fabio
Savarino, Edoardo
Spolverato, Gaya
Fassan, Matteo
author_sort Businello, Gianluca
collection PubMed
description The comprehensive molecular characterization of gastric and gastroesophageal junction adenocarcinomas has led to the improvement of targeted and more effective treatments. As a result, several biomarkers have been introduced into clinical practice and the implementation of innovative diagnostic tools is under study. Such assessments are mainly based on the evaluation of limited biopsy material in clinical practice. In this setting, the pathologist represents a key player in the selection of patients facilitating precision medicine approaches.
format Online
Article
Text
id pubmed-9852175
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-98521752023-01-21 Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter Businello, Gianluca Angerilli, Valentina Lonardi, Sara Bergamo, Francesca Valmasoni, Michele Farinati, Fabio Savarino, Edoardo Spolverato, Gaya Fassan, Matteo Updates Surg Consensus Conference The comprehensive molecular characterization of gastric and gastroesophageal junction adenocarcinomas has led to the improvement of targeted and more effective treatments. As a result, several biomarkers have been introduced into clinical practice and the implementation of innovative diagnostic tools is under study. Such assessments are mainly based on the evaluation of limited biopsy material in clinical practice. In this setting, the pathologist represents a key player in the selection of patients facilitating precision medicine approaches. Springer International Publishing 2022-07-14 2023 /pmc/articles/PMC9852175/ /pubmed/35834132 http://dx.doi.org/10.1007/s13304-022-01330-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Consensus Conference
Businello, Gianluca
Angerilli, Valentina
Lonardi, Sara
Bergamo, Francesca
Valmasoni, Michele
Farinati, Fabio
Savarino, Edoardo
Spolverato, Gaya
Fassan, Matteo
Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
title Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
title_full Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
title_fullStr Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
title_full_unstemmed Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
title_short Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
title_sort current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
topic Consensus Conference
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852175/
https://www.ncbi.nlm.nih.gov/pubmed/35834132
http://dx.doi.org/10.1007/s13304-022-01330-5
work_keys_str_mv AT businellogianluca currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT angerillivalentina currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT lonardisara currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT bergamofrancesca currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT valmasonimichele currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT farinatifabio currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT savarinoedoardo currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT spolveratogaya currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter
AT fassanmatteo currentmolecularbiomarkersevaluationingastricgastroesophagealjunctionadenocarcinomapathologistdoesmatter

Ejemplares similares